Medicines for Europe has met with a high-level Ukrainian government delegation led by Maryna Slobodnichenko, the country’s deputy minister of health for European integration, putting forward ideas on how to plan the integration process of Ukraine into the EU.
Generics Industry Preps For Potential Entry Of Ukraine Into EU
Generics Industry Has Provided Substantial Support Since Russian Invasion
Generics industry trade group Medicines for Europe has met with Ukrainian government officials to discuss how to plan for any future integration process.
More from Generics
More from Products
• By
Samsung Bioepis and Teva have provided clarity on the pricing of their Epysqli biosimilar to Soliris in the US, as the firms launched only the second rival to the rare diseases treatment.
• By
The EMA’s latest move towards a more streamlined process for biosimilar registration in Europe was the hottest topic at last week’s annual biosimilars conference held by Medicines for Europe in Amsterdam. Generics Bulletin discusses the new draft reflection paper and its significance for industry, reports on reactions from the event, and reveals the next steps unveiled by EMA officials.
• By
Meitheal Pharmaceuticals said that its generic version of the GLP-1 agonist Victoza would be one of 22 planned launches during 2025, as the firm continues to build out its portfolio with the aid of its parent, Hong Kong King-Friend Industrial.